Mail

HSIC - Henry Schein, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

67.92

+0.83 (+1.24%)

At close: 4:00PM EDT

Stock chart is not supported by your current browser

Previous Close	67.09
Open	66.75
Bid	0.00 x 800
Ask	69.58 x 800
Day's Range	66.68 - 68.11
52 Week Range	53.91 - 71.65
Volume	1,972,682
Avg. Volume	1,758,720

Market Cap	10.125B
Beta (3Y Monthly)	0.87
PE Ratio (TTM)	20.53
EPS (TTM)	3.31
Earnings Date	Aug 5, 2019 - Aug 9, 2019
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	66.93

Trade prices are not sourced from all markets

All

News

Press Releases

Motley Fool4 days ago
Covetrus, Inc. (CVET) Q1 2019 Earnings Call Transcript
CEVT earnings call for the period ending March 31, 2019.
Thomson Reuters StreetEvents7 days ago
Edited Transcript of HSIC earnings conference call or presentation 7-May-19 2:00pm GMT
Q1 2019 Henry Schein Inc Earnings Call
Simply Wall St.12 days ago
How Do Analysts See Henry Schein, Inc. (NASDAQ:HSIC) Performing In The Next Couple Of Years?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! The latest earnings update Henry Schein, Inc. (NASDAQ:HSIC) released in December 2018 revealed...
Motley Fool12 days ago
Henry Schein (HSIC) Q1 2019 Earnings Call Transcript
HSIC earnings call for the period ending March 31, 2019.
Motley Fool12 days ago
Why Henry Schein, Dean Foods, and SolarEdge Jumped Today
See how these three stocks resisted the broader market's decline.
Associated Press12 days ago
AIG and SolarEdge rise while Mylan and Phibro fall
Stocks that moved substantially or traded heavily on Tuesday: American International Group Inc., up $3.19 to $50.30 The insurer reported solid underwriting gains in the first quarter and profit beat Wall ...
Zacks13 days ago
Henry Schein's (HSIC) Q1 Earnings, Revenues Beat Estimates
Henry Schein's (HSIC) strong share gains in the North American market raise optimism.
Markit13 days ago
See what the IHS Markit Score report has to say about Henry Schein Inc.
Henry Schein Inc NASDAQ/NGS:HSICView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is moderate * Economic output in this company's sector is expanding Bearish sentimentShort interest | NegativeShort interest is moderately high for HSIC with between 10 and 15% of shares outstanding currently on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding HSIC totaled $6.23 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Associated Press13 days ago
Henry Schein: 1Q Earnings Snapshot
The Melville, New York-based company said it had profit of 73 cents per share. Earnings, adjusted for one-time gains and costs, were 80 cents per share. The results surpassed Wall Street expectations. ...
Business Wire13 days ago
Henry Schein Reports Record First Quarter 2019 Financial Results from Continuing Operations
“We will continue to focus on supporting our customers around the world with the broadest array of products and services, along with innovative technology that expands our value-ad
Investing.com13 days ago
Henry Schein Earnings Beat, Revenue Misses In Q1
Investing.com - Henry Schein (NASDAQ:HSIC) reported first quarter earnings that Beat analysts' expectations on Tuesday and revenue that fell short of forecasts.
TheStreet.com14 days ago
Henry Schein Expected to Earn 75 Cents a Share
is expected to report quarterly earnings of 75 cents a share on sales of $2.4 billion before the market opens on Tuesday, based on a FactSet survey of 15 analysts. Quarterly estimates have risen less than 1 cent a share in the past month. Henry Schein is currently trading at a price-to-forward-earnings ratio of 17.8 based on the 12-month estimates of 18 analysts surveyed by FactSet.
Business Wire19 days ago
Henry Schein to Present at Three Conferences in May
Henry Schein, Inc. , the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that the Comp
Zacks20 days ago
Analysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InvestorPlace24 days ago
4 Health Care Stocks That Are Starting to Heat Up
U.S. equities are coming under some pressure on Friday, as investors cool their heels after a run to new record highs. A surprisingly strong Q1 GDP report raised a lot of eyebrows and is calling into question hopes of Federal Reserve interest rate cuts. In fact, with energy prices rising powerfully in recent weeks, and with the economy catting a tailwind, further rate hikes cannot be dismissed.This whipsawing of sentiment is resulting in some profit-taking. And some sector rotation as well.Energy stocks, which have been hot, are cooling a bit after President Trump said he called OPEC and they are going to ramp production in response to its efforts to cut oil exports out of Venezuela and Iran. In their place, health care stocks are perking up.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 A-Rated Stocks That Are Under $10 Here are four health care stocks in the group that are worth a look now: Johnson & Johnson (JNJ) Click to EnlargeShares of Johnson & Johnson (NYSE:JNJ) look ready to push up and out of their three-month consolidation range with a challenge of triple-top resistance near the $140-a-share level. Watch for a move to the December high, which would be worth a gain of nearly 6% from here. The company announced earlier this week that it would increase its quarterly dividend by more than 5%.The company will next report results on July 16 before the bell. Analysts are looking for earnings of $2.42 per share on revenues of $20.3 billion. When the company last reported results on April 16, earnings of $2.1 beat estimates by 6 cents on a 0.1% rise in revenues. Align Technology (ALGN) Click to EnlargeShares of Align Technology (NASDAQ:ALGN), a medical device company behind products like Invisalign, are breaking out of a month-long flirtation with its 200-day moving average returning to levels not seen since late October. Watch for a return to the highs seen in September, which would be worth a gain of nearly 30% from here. * 5 Cheap Energy Stocks to Buy Under $10 The company will next report results on July 24 after the close. Analysts are looking for earnings of $1.5 per share on revenues of $596.3 million. When the company last reported on April 24, earnings of 89 cents per share beat estimates by 6 cents on a 25.7% rise in revenues. Quest Diagnostics (DGX) Click to EnlargeShares of Quest Diagnostics (NYSE:DGX) are pushing up and over their 200-day moving average, challenging the highs set back in November. This has set up a roll-up to the upper end of a sideways range that goes back to early 2017. Shares were recently upgraded by Jefferies analysts, who are looking for a price target of $107.The company will next report results on July 23 before the bell. Analysts are looking for earnings of $1.7 per share on revenues of $1.95 billion. When the company last reported on April 23, earnings of $1.40 beat estimates by 2 cents on a 0.4% rise in revenues. Henry Schein (HSIC) Click to EnlargeShares of Henry Schein (NASDAQ:HSIC), a provider of health care products and services to dental offices, is enjoying a share price breakout to levels not seen since early December. Powered with momentum from a move above both its 50-day and 200-day moving averages, watch for a challenge of recent highs near $70, which would be worth a gain of more than 10% from here. * 10 Automation Stocks to Buy for the 21st Century The company will next report on May 7 before the bell. Analysts are looking for earnings of 76 cents per share on revenues of $3.3 billion. When the company last reported on Feb. 20, earnings of $1.12 beat estimates by a penny on a 1.7% rise in revenues.As of this writing, William Roth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 5 Hot Dividend Stocks to Buy as the Weather Heats Up * 7 Dividend Stocks That Could Double Over the Next Five Years * 10 Stocks to Sell Before They Give Back 2019 Gains * 7 Cloud Stocks to Buy Now Compare Brokers The post 4 Health Care Stocks That Are Starting to Heat Up appeared first on InvestorPlace.
Business Wire25 days ago
Henry Schein Medical and MindChild Medical Announce an Exclusive Distribution and Supply Agreement for the MERIDIAN M110 Fetal Monitoring System
System Uses Surface Electrodes to Monitor Highly Accurate, Non-Invasive Fetal and Maternal Heart Rate and Uterine Contraction
Simply Wall St.26 days ago
Do You Know What Henry Schein, Inc.'s (NASDAQ:HSIC) P/E Ratio Means?
Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. We'll show how you can use Henry Schein, Inc.'s (NASDAQ:HSIC) P/E ratio to inform your assessment of the investment opportunity. H...
Business Wire26 days ago
Henry Schein Medical Announces Private Label-Branded Product, OneStep™ + Pro Hb Analyzer
Company to Offer Practitioners Point-of-Care Hemoglobin Analyzer for Fast Delivery of Blood Test Results
Business Wire27 days ago
Henry Schein to Webcast First Quarter 2019 Conference Call on Tuesday, May 7, 2019 at 10:00 A.M. Eastern Time
Henry Schein, Inc. (HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced today that it will release its first quarter 2019 financial results before the stock market opens on Tuesday, May 7, 2019, and will provide a live webcast of its earnings conference call on the same day beginning at 10:00 a.m. Eastern time. Speakers on the call will include Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, and Steven Paladino, the Company's Executive Vice President and Chief Financial Officer. Investors can access the call through Henry Schein's website at www.henryschein.com, by clicking on the “Investor Relations” page and following the link for “Webcasts.” For those unable to listen to the live webcast, a replay will be archived on the Henry Schein website.
InvestorPlacelast month
7 Dental Stocks to Buy That Will Make You Smile
A few years ago I was sitting in the dentist chair for my six-month examination and teeth cleaning. As I stared at the ceiling, I couldn't help notice the name Belmont on the arm of the bright light burning a hole in my retina. I couldn't help myself, asking the dentist if she'd ever invested in a dental-related company? She said she hadn't. "Not even Henry Schein (NASDAQ:HSIC)?", I asked. Nope. That was the end of the investment discussion. Recently, I saw an article that said dental startups such as Candid and Smile Direct Club, which provides systems for mild-to-moderate teeth straightening -- saving you a bundle in the process -- have investors lining up to invest in the private companies. InvestorPlace - Stock Market News, Stock Advice & Trading TipsOf course, that brought me back to that day in the dentist's chair, when I wondered about stocks to buy that will make you smile. * 10 Stocks That Are Screaming Buys Right Now Here are seven names I've identified that will put money in your pockets. Henry Schein (HSIC)Source: Shutterstock If you're a dentist, you've likely got Henry Schein on speed dial. It distributes more than 120,000 branded products and another 180,000 private label products to dentists and medical practitioners. It is the No. 1 global dental distributor and the No. 2 physician and alternate care distributor in the U.S. In fact, 90% of U.S. dental practices are active Schein customers. So, the next time you go to the dentist, be sure to ask how much stuff they buy from the company. It's probably a lot. Things seem to be going smoothly for the Melville, New York, company, yet HSIC is currently trading within 13% of its 52-week low and up less than 5% year-to-date through April 10, one-third the performance of the S&P 500.On three occasions over the past five years, it traded below $55. Within five dollars of doing so a fourth time, HSIC is entering value territory. Fear not. In 2018, Henry Schein's revenues grew by 5.9% year-over-year to $13.2 billion, while its non-GAAP earnings rose 11.4% to $635.3 million, its highest level of sales and profits in its history. Now, exclusively a company dealing with humans after spinning off its animal health business, Henry Schein is ready to take dental to the next level. 3D Systems (DDD)Source: Image via 3D Systems3D Systems (NYSE:DDD) is a 3D printer. Over the past five years as the demand for 3D printing has slowed, so too has the company's revenue and earnings growth. As a result, DDD shares have lost 80% of their value. In 2019, DDD is up more than 7% year-to-date through April 10. However, it lost a great deal of its momentum in March, giving back 23% of its gains on the year. The company's dental segment continues to take a bite out of the competition. It produces dentures, crowns and surgical guides. "There are billions of opportunities here, since virtually anybody could benefit from 3-D printed dental solutions," said CEO Vyomesh Joshi recently. On a non-GAAP basis, 3D Systems went from a $1.7 million loss in 2017 to a $16.5 million gain in 2018 on the strength of a 6% increase in revenue to $688 million. * 10 Dow Jones Stocks Holding the Blue Chip Index Back Trading at 1.8 times revenue, less than half its five-year average price-to-sales ratio, DDD provides investors with an excellent value proposition. Align Technology (ALGN)Source: Shutterstock As dentists go, mine wasn't too pushy about trying the latest and greatest dental product or service, but she sure liked to talk up Invisalign, the $8,000 clear aligner that straightens your teeth. Made by Align Technology (NASDAQ:ALGN), I never took the bait. Now, having moved from Toronto to Halifax over a year ago, and still without a new dentist, I suspect I'll soon be getting the Invisalign sales pitch a second time. Perhaps, startups like Candid are taking a bite out of Align's market share. Given the $4,000 price over 24 months for its teeth alignment product, a good $3,000-$4,000 cheaper than the competition, it's easy to see why. However, I don't think investors should give up on ALGN just yet. As I look at the company's results for 2018, I see a lot of positives.On the top line, revenues grew 34% to $2 billion, a company record, on a 32% increase in Invisalign volume. On the bottom line, net profits were $400.2 million in 2018, 73% higher than a year ago. Forget for a moment that Invisalign didn't exist. Its iTero scanners experienced 68% growth in 2018; iTero's revenues now account for 14% of Align's overall revenue, up 290 basis points from 2017. Trading well off its all-time high of $398.88, investors buying in today, should have significant upside in the months ahead. Dentsply Sirona (XRAY)Source: Shutterstock I first became familiar with Dentsply Sirona (NASDAQ:XRAY) way back in March 2013, more than two years before Dentsply would pay $5.5 billion for Sirona Dental Systems, a company I liked because of its diversified revenue streams. "Sirona's revenue diversification is what makes it such a good company. It generates business from four operating segments: Dental CAD/CAM Systems, Imaging Systems, Treatment Centers, and Instruments," I wrote March 20, 2013. "Its CAD/CAM and Imaging Systems accounted for 70% of its overall revenue in the first quarter ended December 2012."If you took my advice and bought 100 shares of Sirona at the Q2 2013 high of $73.98, today you'd have $9,158, a 24% return. But over three years, it's seen a mediocre 5% return. So, do I still think XRAY is worth holding for the long haul?I do. Here's why.Like most acquisitions, the tie-up didn't go nearly as smoothly as hoped. As a result, the company was forced to implement a turnaround plan that will simplify its business. Where have I heard that before?Anyway, when you bring together two reasonably large businesses, you often lose focus on parts of it and those units suffer. So, it's exiting these businesses and cutting staffing by as much as 8%. By fiscal 2020, analysts expect it to earn $2.64 a share, its best earnings performance since 2016. * The 7 Best Long-Term Stocks for 2019 And Beyond It has had a good run in 2019, up 36% year-to-date. I'd be patient and try to buy on weakness in the mid-$40s. Patterson Companies (PDCO)Source: Shutterstock A little over two years ago, Globe and Mail business reporter Scott Barlow highlighted 12 healthcare stocks that had stable cash flow. He argued that businesses such as Patterson Companies (NASDAQ:PDCO), a distributor of dental and animal health products, would make you rich over the long haul because of this critical attribute. Since the article, PDCO stock has lost approximately half its value. Ouch.However, in the nine months ended Jan. 27, 2019, Patterson's operating cash flow increased 91% to $76.3 million. After subtracting $33.9 million in capital expenditures, it generated free cash flow of $42.4 million or 77% of its net income. On the top line, revenues in the first three quarters of fiscal 2019 barely budged, up 1.8% to $4.14 billion. On the bottom line GAAP basis, its net income fell 69% to $55.2 million. On an adjusted basis, earnings fell 25% to $95.9 million. While this article is about dental businesses, Patterson's animal health business (58% of revenue) continues to provide PDCO with diversified revenue streams that will protect it when the economy turns south because a lot of pet owners won't scrimp on their companion animal's wellbeing. Yielding 4.8% at the moment, it has plenty of free cash flow to keep paying its juicy dividend. If you're an income investor, PDCO is an excellent stock to own before the company's restructuring takes hold. Get paid to wait. Procter & Gamble (PG)Source: Mike Mozart via Flickr (Modified)My old dentist's dental technician recommended that I buy an Oral-B electric toothbrush because it does a better job of brushing your teeth without overdoing it, thus hurting your gums. She was right. Originally invented in 1950 by California periodontist Dr. Robert Hutson, he sold the company to Cooper Laboratories, who in turn sold it to Gillette in 1984 for $188.5 million. The rest, as they say, is history. On April 9, Oral-B's owner, Procter & Gamble (NYSE:PG), raised its quarterly dividend by 4% to 74.59 cents a share, an annualized rate of $2.98, yielding 2.8% despite a 37% gain over the past 52 weeks. This is P&G's 63rd consecutive year increasing its dividend. Oral-B and the rest of its oral care brands generated 9% of P&Gs revenue in the second quarter. Part of the healthcare segment, sales and earnings were both up slightly in the first quarter, delivering solid if not spectacular results. * The 10 Fastest-Growing Stocks to Invest In Right Now Consider Oral-B the company's slow-growth business. Overall, however, Procter & Gamble is doing just fine. Church & Dwight (CHD) Source: slgckgc via Flickr (Modified)Church & Dwight (NYSE:CHD) is a smaller version of P&G. But make no mistake, it competes with the best of them. As far as dental care goes, it has Arm & Hammer, AIM, Close-Up and Pepsodent toothpaste. Other brands include Orajel and Waterpik. The company has become adept at making smaller acquisitions and then growing those businesses over time. Most recently, it announced it had acquired two hair removal brands, Flawless and Finishing Touch, for $475 million and a further $425 million in potential earnouts. The two brands add $180 million in annual revenue and $55 million in EBITDA.The owners of Flawless would have been wise to ask for stock instead of cash because over the past decade, CHD stock has delivered an annualized total return of 19.4%, almost double P&G.As stocks go, CHD is a perfect 10. I urge you to check it out. At the time of this writing, Will Ashworth did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Internet Stocks to Watch * 7 AI Stocks to Watch with Strong Long-Term Narratives * 10 Dow Jones Stocks Holding the Blue Chip Index Back Compare Brokers The post 7 Dental Stocks to Buy That Will Make You Smile appeared first on InvestorPlace.
Simply Wall St.last month
Does Henry Schein, Inc.'s (NASDAQ:HSIC) 31% Earnings Growth Reflect The Long-Term Trend?
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Analyzing Henry Schein, Inc.'s (NASDAQ:HSIC) track record of past performance is a valuable exercise for investors. It enable...
PR Newswirelast month
Henry Schein Medical and Henry Schein Cares Foundation Partner with Children's Health Fund to Help Enhance Access to Care for Underprivileged Children Throughout the United States
Nearly $525,000 in Funds and Health Care Products Donated to Support 12 Pediatric Health Programs MELVILLE, N.Y. , April 9, 2019 /PRNewswire/ -- Henry Schein Medical, the U.S. medical business of Henry ...
PR Newswirelast month
Henry Schein Sponsors 13th Annual Senior Dental Leaders Programme At Harvard University
MELVILLE, N.Y., April 8, 2019 /PRNewswire/ -- Henry Schein, Inc. (HSIC) demonstrated its commitment to expanding access to health care and developing high-level capabilities in oral health leaders from around the world by sponsoring the Senior Dental Leaders Programme for a 13th year. First conceived in 2007 at King's College London by Professor Raman Bedi, DDS, the programme is attended by a diverse cohort from within the international dental community working collaboratively toward a cavity-free world for children, including dental policymakers, national Chief Dental Officers, representatives from non-governmental organizations, members of the clinical and academic communities, and other stakeholders.